From the Department of Pathology and Laboratory Medicine, Emory University Hospital, Atlanta, Georgia (Gonzalez).
Unit of Pathology, Department of Medicine and Surgery, University of Insubria, Varese, Italy (La Rosa).
Arch Pathol Lab Med. 2024 May 1;148(5):581-587. doi: 10.5858/arpa.2023-0169-OA.
Recent data suggest mesenteric tumor deposits (MTDs) indicate poor prognosis in small bowel well-differentiated neuroendocrine tumors (SB-NETs), including compared to positive lymph nodes, making their distinction crucial.
To study interobserver agreement in distinguishing SB-NET MTDs from positive nodes.
Virtual slides from 36 locally metastatic SB-NET foci were shared among 7 gastrointestinal pathologists, who interpreted each as an MTD or a positive node. Observers ranked their 5 preferred choices among a supplied list of potentially useful histologic features, for both options. Diagnostic opinions were compared using Fleiss multirater and Cohen weighted κ analyses.
Preferred criteria for MTD included irregular shape (n = 7, top choice for 5), perineural invasion/nerve entrapment (n = 7, top choice for 2), encased thick-walled vessels (n = 7), and prominent fibrosis (n = 6). Preferred criteria for positive nodes included peripheral lymphoid follicles (n = 6, top choice for 4), round shape (n = 7, top choice for 2), peripheral lymphocyte rim (n = 7, top choice for 1), subcapsular sinuses (n = 7), and a capsule (n = 6). Among 36 foci, 10 (28%) each were unanimously diagnosed as MTD or positive node. For 13 foci (36%), there was a diagnosis favored by most observers (5 or 6 of 7): positive node in 8, MTD in 5. Only 3 cases (8%) had a near-even (4:3) split. Overall agreement was substantial (κ = .64, P < .001).
Substantial interobserver agreement exists for distinguishing SB-NET MTDs from lymph node metastases. Favored histologic criteria in making the distinction include irregular shape and nerve/vessel entrapment for MTD, and peripheral lymphocytes/lymphoid follicles and round shape for positive nodes.
最近的数据表明,肠系膜肿瘤沉积(MTDs)表明小肠分化良好的神经内分泌肿瘤(SB-NET)预后不良,包括与阳性淋巴结相比,因此区分它们至关重要。
研究区分 SB-NET MTD 与阳性淋巴结的观察者间一致性。
36 个局部转移性 SB-NET 病灶的虚拟切片在 7 位胃肠病理学家之间共享,每位病理学家将其解读为 MTD 或阳性淋巴结。观察者对其 5 个首选选项进行了排名,这些选项来自于一个可能有用的组织学特征列表,对于这两个选项都是如此。使用 Fleiss 多评估者和 Cohen 加权κ分析比较诊断意见。
MTD 的首选标准包括不规则形状(n = 7,5 个为首选)、神经周围浸润/神经嵌塞(n = 7,2 个为首选)、包裹厚壁血管(n = 7)和明显纤维化(n = 6)。阳性淋巴结的首选标准包括周围淋巴滤泡(n = 6,4 个为首选)、圆形(n = 7,2 个为首选)、周围淋巴细胞缘(n = 7,1 个为首选)、包膜下窦(n = 7)和包膜(n = 6)。在 36 个病灶中,每个病灶均被一致诊断为 MTD 或阳性淋巴结(28%)。对于 13 个病灶(36%),大多数观察者都倾向于诊断(7 位中的 5 位或 6 位):8 个为阳性淋巴结,5 个为 MTD。只有 3 个病例(8%)的诊断结果接近均等(4:3)。总体一致性较高(κ =.64,P <.001)。
区分 SB-NET MTD 与淋巴结转移的观察者间一致性较高。在做出区分时,首选的组织学标准包括 MTD 的不规则形状和神经/血管嵌塞,以及阳性淋巴结的周围淋巴细胞/淋巴滤泡和圆形。